title: LTK63 and LTR72, two mucosal adjuvants ready for clinical trials.
authors: IRIS, Chiron SpA, Siena, Italy. pizza@iris02@biocine.it
authors: M
authors: M
authors: Pizza
authors: M M
authors: MM
authors: Giuliani
authors: M R
authors: MR
authors: Fontana
authors: G
authors: G
authors: Douce
authors: G
authors: G
authors: Dougan
authors: R
authors: R
authors: Rappuoli
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001427:Bacterial Toxins / Q000737:chemistry / Q000276:immunology / Q000494:pharmacology*; D020134:Catalytic Domain; D002772:Cholera Toxin / Q000737:chemistry / Q000276:immunology / Q000494:pharmacology*; D004768:Enterotoxins / Q000737:chemistry / Q000276:immunology / Q000494:pharmacology*; D029968:Escherichia coli Proteins; D006801:Humans; D051379:Mice; D011817:Rabbits; D013329:Structure-Activity Relationship
chemical_list: D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D002772:Cholera Toxin; C027538:heat-labile enterotoxin, E coli